Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation

ABSTRACT: COVID-19 pandemic caused by the SARS-CoV-2 virus has led to a worldwide crisis. In view of emerging variants time to time, there is a pressing need of effective COVID-19 therapeutics. Setomimycin, a rare tetrahydroanthracene antibiotic, remained unexplored for its therapeutic uses. Herein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Manhas, Ravi S., Tiwari, Harshita, Noor, Mateen, Ahmed, Ajaz, Vishwakarma, Jyoti, Tripathi, Raja B. M., Ramachandran, Ravishankar, Madishetti, Sreedhar, Mukherjee, Debaraj, Nargotra, Amit, Chaubey, Asha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136828/
https://www.ncbi.nlm.nih.gov/pubmed/35622309
http://dx.doi.org/10.1007/s11030-022-10441-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136828/
https://www.ncbi.nlm.nih.gov/pubmed/35622309
http://dx.doi.org/10.1007/s11030-022-10441-5

Ejemplares similares